Homepage Featured News

December 9, 2024

The 50 greatest innovations of 2024: Shield Blood Test

Blood tests for cancer are here and Guardant Health is leading the charge

October 30, 2024

TIME’s Best Inventions of 2024: Shield Blood Test

September 11, 2024

Opinion | Science Finds New Ways to Detect Cancer, but Politics Gets in the Way

July 16, 2024

It’s Time for a New Option in Colorectal Cancer Screening

May 30, 2024

TIME100 Most Influential Companies 2024: Guardant Health

May 13, 2024

Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test

March 19, 2024

Meet the Diagnostics Company Helping Find Cancer and Choose the Right Treatment

July 5, 2023

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

Reimbursement supports expanded access to blood-based comprehensive genomic profiling with Guardant360 CDx for patients with advanced solid tumor cancers and their care teams across Japan

May 31, 2023

Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting

New research further confirms value of interrogating epigenomic signals with Guardant Infinity™ platform to identify novel biomarker targets and predict treatment resistance